Podstawa prawna: art. 56. 1. 2 of Act on Public Offering.
„Sopharma” AD (the Company notifies that for January 2022 the Company recorded an increase in sales of 51% compared to the same month of the previous year, incl. normalization of domestic sales with an increase of 254% due to the low base and 35% decrease in export sales.
Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1
kom espi zdz
